Identifysensors biologics partners with jabil healthcare to manufacture digital diagnostic platform

Cleveland , july 12, 2022 /prnewswire/ -- identifysensors biologics, a pathogen-detection platform technology company, has partnered with jabil inc. (nyse: jbl), a global manufacturing solutions company, to develop processes for reliable robust manufacturing of portable devices that rapidly detect a wide range of infections at the molecular level with accuracy that is superior to pcr testing. a new portable digital reader now detects multiple infections from saliva in minutes with pcr accuracy.
JBL Ratings Summary
JBL Quant Ranking